Clinical Trial Update: Capecitabine and Gemcitabine in Treating Patients With Metastatic Kidney Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of capecitabine and gemcitabine in metastatic renal cell carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Capecitabine (capecitabine)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Kidney Cancer | Phase 2 | Status: COMPLETED